Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment
-
Published:2023-12-21
Issue:1
Volume:25
Page:154
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Alipourgivi Faranak12ORCID, Motolani Aishat1, Qiu Alice Y.3, Qiang Wenan3456ORCID, Yang Guang-Yu56, Chen Shuibing7, Lu Tao1289ORCID
Affiliation:
1. Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USA 2. Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USA 3. Center for Developmental Therapeutics, Chemistry of Life Processes Institute, Northwestern University, Evanston, IL 60208, USA 4. Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA 5. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA 6. Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA 7. Department of Surgery, Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065, USA 8. Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA 9. Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Abstract
Colorectal cancer (CRC) is the third leading cause of cancer mortality in the United States, with an estimated 52,000 deaths in 2023. Though significant progress has been made in both diagnosis and treatment of CRC in recent years, genetic heterogeneity of CRC—the culprit for possible CRC relapse and drug resistance, is still an insurmountable challenge. Thus, developing more effective therapeutics to overcome this challenge in new CRC treatment strategies is imperative. Genetic and epigenetic changes are well recognized to be responsible for the stepwise development of CRC malignancy. In this review, we focus on detailed genetic alteration information about the nuclear factor (NF)-κB signaling, including both NF-κB family members, and their regulators, such as protein arginine methyltransferase 5 (PRMT5), and outer dynein arm docking complex subunit 2 (ODAD2, also named armadillo repeat-containing 4, ARMC4), etc., in CRC patients. Moreover, we provide deep insight into different CRC research models, with a particular focus on patient-derived xenografts (PDX) and organoid models, and their potential applications in CRC research. Genetic alterations on NF-κB signaling components are estimated to be more than 50% of the overall genetic changes identified in CRC patients collected by cBioportal for Cancer Genomics; thus, emphasizing its paramount importance in CRC progression. Consequently, various genetic alterations on NF-κB signaling may hold great promise for novel therapeutic development in CRC. Future endeavors may focus on utilizing CRC models (e.g., PDX or organoids, or isogenic human embryonic stem cell (hESC)-derived colonic cells, or human pluripotent stem cells (hPSC)-derived colonic organoids, etc.) to further uncover the underpinning mechanism of these genetic alterations in NF-κB signaling in CRC progression. Moreover, establishing platforms for drug discovery in dishes, and developing Biobanks, etc., may further pave the way for the development of innovative personalized medicine to treat CRC in the future.
Funder
National Institutes of Health NIH-NCI
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference97 articles.
1. Cancer Statistics, 2023;Siegel;CA Cancer J. Clin.,2023 2. Symptom Experiences in Colorectal Cancer Survivors after Cancer Treatments: A Systematic Review and Meta-Analysis;Han;Cancer Nurs.,2020 3. Specific and Non-Specific Symptoms of Colorectal Cancer and Contact to General Practice;Rasmussen;Fam. Pract.,2015 4. Hossain, M.S., Karuniawati, H., Jairoun, A.A., Urbi, Z., Ooi, D.J., John, A., Lim, Y.C., Kibria, K.M.K., Mohiuddin, A.K.M., and Ming, L.C. (2022). Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers, 14. 5. Colorectal Cancer Heterogeneity and Targeted Therapy: Clinical Implications, Challenges and Solutions for Treatment Resistance;Zhai;Semin. Cell Dev. Biol.,2017
|
|